Nbw Capital LLC Johnson & Johnson Transaction History

Nbw Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 13, 2024	BUY	$155.22 - $162.74 $44,703 - $46,869	288 Added 22.29%	1,580 $249,000
Q4 2023 Jan 31, 2024	SELL	$145.6 - $158.88 $42,515 - $46,392	-292 Reduced 18.43%	1,292 $202,000
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $25,854 - $28,963	-166 Reduced 9.49%	1,584 $246,000
Q2 2023 Aug 15, 2023	BUY	$154.35 - $166.11 $49,392 - $53,155	320 Added 22.38%	1,750 $289,000
Q1 2023 May 11, 2023	BUY	$151.05 - $180.26 $216,001 - $257,771	1,430 New	1,430 $221,000
Q2 2022 Aug 01, 2022	SELL	$168.19 - $186.01 $193,923 - $214,469	-1,153 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$158.14 - $179.59 $182,335 - $207,067	1,153 New	1,153 $204,000

4,239

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Nbw Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Nbw Capital LLC with notifications on news.